Source link : https://www.newshealth.biz/health-news/colchicine-may-benefit-patients-with-diabetes-and-recent-mi/
TOPLINE: A daily low dose of colchicine significantly reduces ischemic cardiovascular events in patients with type 2 diabetes (T2D) and a recent myocardial infarction (MI). METHODOLOGY: After an MI, patients with vs without T2D have a higher risk for another cardiovascular event. The Cochicine Cardiovascular Outcomes Trial (COLCOT), a randomized, double-blinded trial, found a lower […]
Author : News Health
Publish date : 2024-01-25 13:06:59
Copyright for syndicated content belongs to the linked Source.